Daruka Mahadevan, MD, PhD (he/him/his)

Division Chief Hematology/Oncology
UT Health San Antonio
San Antonio, Texas, United States

Disclosure information not submitted.

Presentation(s):

• Paper 31 - EFFICACY AND SAFETY OF BOTENSILIMAB PLUS BALSTILIMAB COMBINATION THERAPY IN REFRACTORY METASTATIC SARCOMA PATIENTS: FINDINGS FROM AN ONGOING EXPANDED PHASE 1B STUDY

  Friday, November 3, 2023
  9:00 AM – 10:00 AM